COVID-19 Increases the Rate of Incident Diabetes: A Case-Control Cohort Time-to-Event Study

BackgroundOf the hundreds of millions of COVID-19 cases globally, most have been non-fatal, though "Long COVID" after acute infection has been documented in many. While studies report post-COVID increases chronic disease incidence including diabetes mellitus (DM), they frequently underrepresent racial/ethnic minorities and lack controls for potential confounds (e.g., increased DM testing after COVID-19). MethodsWe conducted a case-control cohort time-to-event study of 29,470 individuals incarcerated in 31 California state prisons. The main outcome was incident diagnosed DM among individuals incarcerated continuously since January 1, 2019 with no DM diagnosis prior to March 1, 2020 (beginning of the unexposed period of observation). The main exposure was a positive COVID-19 test, with the exposure period beginning 31 days afterwards (post-acute period). Covariates included age, gender, race/ethnicity, BMI, and blood glucose at the start of the pandemic, frequency of healthcare contacts prior to the pandemic, and COVID-19 testing frequency prior to testing positive. We excluded individuals who lacked BMI or blood glucose measurements prior to or during the pandemic or were never tested for COVID-19 along with those who had been prescribed blood glucose-altering medications or had a diagnosed condition that could alter blood glucose. We estimated multivariate Cox proportional hazard models: 1) exposure variable and all covariates; 2) adding interactions between the exposure and each covariate. We assessed whether confounding due to changes in DM testing post-COVID could explain our results. ResultsCOVID-19 infection significantly increased the rate of incident DM (main effects model HRR: 1.17 [95%CI: 1.03-1.34]; no significant interaction effects were observed). If all individuals in our study had had a COVID-19 infection, the 2-year cumulative risk of DM would have been 3.2% [2.5%-3.9%] compared to 2.7% [2.1%-3.4%] if none had been infected. While our findings were consistent to different definitions of the post-acute COVID period, confounding due to changes in DM testing post-COVID may imply that the effect is halved (HRR: 1.08-1.10). ConclusionCOVID-19 may increase the risk of incident DM long after acute infection, warranting additional provider awareness and clinical consideration.